INGN Inogen, Inc.
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.96
P/S
0.49
EV/EBITDA
-18.59
DCF Value
$-6.53
FCF Yield
-5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.7%
Operating Margin
-8.8%
Net Margin
-7.1%
ROE
-12.9%
ROA
-8.7%
ROIC
-13.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $85.1M | $-8.3M | $— |
| Q4 null | $81.7M | $-7.1M | $— |
| FY null | $348.7M | $-22.7M | $— |
| Q3 null | $92.4M | $-5.3M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$26.00
Target (Median)
$26.00
Target Range
$26.00 - $26.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.65
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.